Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS)
CUSIP: 15117K103
Q2 2016 13F Holders as of 30 Jun 2016
- Type / Class
- Equity / Ordinary Shares, nominal value EUR0.05 per share
- Shares outstanding
- 95,490,450
- Total 13F shares
- 6,932,847
- Share change
- +476,384
- Total reported value
- $184,344,000
- Price per share
- $26.59
- Number of holders
- 38
- Value change
- +$12,602,577
- Number of buys
- 17
- Number of sells
- 16
Quarterly Holders Quick Answers
What is CUSIP 15117K103?
CUSIP 15117K103 identifies CLLS - Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 15117K103:
Top shareholders of CLLS - Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
3.7%
|
3,507,761
|
$96,463,000 | — | 31 Mar 2016 | |
| Cormorant Asset Management, LP |
13F
|
Company |
0.49%
|
469,145
|
$12,901,000 | — | 31 Mar 2016 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.37%
|
350,000
|
$9,625,000 | — | 31 Mar 2016 | |
| Tekla Capital Management LLC |
13F
|
Company |
0.32%
|
310,250
|
$8,532,000 | — | 31 Mar 2016 | |
| LAZARD ASSET MANAGEMENT LLC |
13F
|
Company |
0.27%
|
259,063
|
$7,124,000 | — | 31 Mar 2016 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.26%
|
243,700
|
$6,702,000 | — | 31 Mar 2016 | |
| Artal Group S.A. |
13F
|
Company |
0.22%
|
210,000
|
$5,775,000 | — | 31 Mar 2016 | |
| TAUBE HODSON STONEX PARTNERS LLP |
13F
|
Company |
0.18%
|
170,112
|
$4,678,000 | — | 31 Mar 2016 | |
| CLOUGH CAPITAL PARTNERS L P |
13F
|
Company |
0.17%
|
160,950
|
$4,426,000 | — | 31 Mar 2016 | |
| Abingworth LLP |
13F
|
Company |
0.1%
|
100,000
|
$2,735,000 | — | 31 Mar 2016 | |
| UBS Group AG |
13F
|
Company |
0.1%
|
92,548
|
$2,545,000 | — | 31 Mar 2016 | |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. |
13F
|
Company |
0.07%
|
71,500
|
$1,966,000 | — | 31 Mar 2016 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.06%
|
55,635
|
$1,530,000 | — | 31 Mar 2016 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.05%
|
51,445
|
$1,415,000 | — | 31 Mar 2016 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.05%
|
50,000
|
$1,375,000 | — | 31 Mar 2016 | |
| Vident Investment Advisory, LLC |
13F
|
Company |
0.05%
|
49,870
|
$1,372,000 | — | 31 Mar 2016 | |
| PUTNAM INVESTMENTS LLC |
13F
|
Company |
0.04%
|
40,000
|
$1,100,000 | — | 31 Mar 2016 | |
| TOCQUEVILLE ASSET MANAGEMENT L.P. |
13F
|
Company |
0.03%
|
28,600
|
$787,000 | — | 31 Mar 2016 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.03%
|
27,654
|
$760,000 | — | 31 Mar 2016 | |
| PICTON MAHONEY ASSET MANAGEMENT |
13F
|
Company |
0.03%
|
26,800
|
$737,000 | — | 31 Mar 2016 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
0.03%
|
25,000
|
$688,000 | — | 31 Mar 2016 | |
| Nicholas Investment Partners, LP |
13F
|
Company |
0.02%
|
18,662
|
$513,000 | — | 31 Mar 2016 | |
| A.R.T. Advisors, LLC |
13F
|
Company |
0.02%
|
17,965
|
$494,000 | — | 31 Mar 2016 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.02%
|
14,687
|
$404,000 | — | 31 Mar 2016 | |
| HighTower Advisors, LLC |
13F
|
Company |
0.01%
|
13,400
|
$369,000 | — | 31 Mar 2016 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.01%
|
13,163
|
$361,000 | — | 31 Mar 2016 | |
| Trexquant Investment LP |
13F
|
Company |
0.01%
|
12,628
|
$347,000 | — | 31 Mar 2016 | |
| OPPENHEIMER & CO INC |
13F
|
Company |
0.01%
|
12,335
|
$339,000 | — | 31 Mar 2016 | |
| DELTEC ASSET MANAGEMENT LLC |
13F
|
Company |
0.01%
|
12,000
|
$330,000 | — | 31 Mar 2016 | |
| Creative Planning |
13F
|
Company |
0.01%
|
9,850
|
$271,000 | — | 31 Mar 2016 | |
| GAM Holding AG |
13F
|
Company |
0.01%
|
9,410
|
$259,000 | — | 31 Mar 2016 | |
| Apex Capital Management |
13F
|
Company |
0.01%
|
9,229
|
$254,000 | — | 31 Mar 2016 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.01%
|
8,130
|
$224,000 | — | 31 Mar 2016 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
4,438
|
$122,000 | — | 31 Mar 2016 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0%
|
2,996
|
$82,000 | — | 31 Mar 2016 | |
| FIRST NEW YORK SECURITIES LLC /NY |
13F
|
Company |
0%
|
2,341
|
$64,378 | — | 31 Mar 2016 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0%
|
1,973
|
$54,000 | — | 31 Mar 2016 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
1,270
|
$35,000 | — | 31 Mar 2016 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
400
|
$11,000 | — | 31 Mar 2016 | |
| D.A. DAVIDSON & CO. |
13F
|
Company |
0%
|
300
|
$8,000 | — | 31 Mar 2016 | |
| Geneos Wealth Management Inc. |
13F
|
Company |
0%
|
247
|
$6,000 | — | 31 Mar 2016 | |
| ADVANTAGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0%
|
200
|
$6,000 | — | 31 Mar 2016 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
35
|
$1,000 | — | 31 Mar 2016 |
Institutional Holders of Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS) as of Q2 2016
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2016 vs Q1 2016 Across Filers
| Investor | Q1 2016 Shares | Q2 2016 Shares | Share Diff | Share Chg % | Q1 2016 Value $ | Q2 2016 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.